Health and Life Sciences
CambridgeIP has extensive experience working in the field of Health and Life Sciences. CambridgeIP has developed unique patent mapping, IP strategy and technology strategy expertise in key Health and Life Sciences areas. We support our clients in their R&D and IP strategy through IP Landscape® and Freedom to Operate (FTO) analysis as well as non-patent Journal Landscape projects conducted by our team of experts. Our experience in the Health and Life Sciences includes work with major pharmaceutical companies, service providers, academic research institutes & individual inventors. CambridgeIP are experts in the fields of medical technology and pharmaceutical formulations, learn more about how we can help you in this sector by visiting our MedTech and Formulations pages.
Download an information sheet about our services
Download a sample recent event presentation on ‘Personalised Medicine: An IP strategy to attract partners’
The extremely diverse field of Health and Life Sciences encompasses a number of rapidly growing industries. For example, in the medical technology space a variety of technological, social and economic factors are driving innovative companies to accelerate product development, whilst in the pharmaceutical formulations space big pharma companies are turning to re-formulation of existing drugs, in response to the impending expiration of their key patents.
Our team covers a broad section of the Health & Life Sciences field. We have developed particular expertise in the following fields:
- Medical Devices
- Active Pharmaceutical Ingredients
- Pharmaceutical Formulations
- Manufacturing Processes
- Over-the-counter Drugs
- Gene Therapy
- Regenerative Medicine
Contact us for a full list of our expertise
Clients use our analysis to meet a range of business development requirements:
- Understand their patent landscape
- Gather competitive intelligence
- Formulate R&D strategies
- Identify collaboration & in-licensing partners
- Enable Freedom to Operate analysis
- Support investment cases
- Undertake M&A due diligence
- Open Innovation
- Highlight Technology ‘white space’
- Inform Investment Opportunities
- Technology Value Chain mapping
- Develop Technology Roadmap
Contact us for a full range of our business solutions
Quentin Tannock (Exec. Chairman) and Dr Anna Duch (Senior Associate) prepared an IP Landscape snapshot of the personalised medicine...
Anna Duch (Associate) presented a poster at MiBio 2013 on ‘Innovation trends in the delivery of therapeutic antibodies’. Using...